Literature DB >> 12170780

Id proteins--tumor markers or oncogenes?

Jens Hasskarl1, Karl Münger.   

Abstract

The Id (Inhibitor of differentiation or Inhibitor of DNA-binding) proteins act as dominant negative inhibitors of differentiation-specific basic Helix-Loop-Helix (bHLH) transcription factors. Id proteins negatively regulate cellular differentiation and they induce proliferation by modulating different cell cycle regulators both by direct and indirect mechanisms. Ectopic expression of Id proteins in tissue culture models can result in cellular immortalization and abrogation of differentiation processes. Recent reports show that Id proteins are overexpressed in various cancer types implying a role of these regulatory proteins in carcinogenesis. This review focuses on the biology of the Id proteins and their role as potential oncogenes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170780     DOI: 10.4161/cbt.50

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

Review 1.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.

Authors:  Valerie Anne Trabosh; Ahmad Daher; Kyle A Divito; Karishma Amin; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Exp Dermatol       Date:  2008-10-23       Impact factor: 3.960

3.  Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Authors:  Jan Harder; Michael J Müller; Matthias Fuchs; Vera Gumpp; Annette Schmitt-Graeff; Richard Fischer; Melanie Frank; Oliver Opitz; Jens Hasskarl
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.

Authors:  Leila Antonângelo; Taila Tuma; Alexandre Fabro; Milena Acencio; Ricardo Terra; Edwin Parra; Francisco Vargas; Teresa Takagaki; Vera Capelozzi
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-10

5.  Dietary fiber enhances TGF-β signaling and growth inhibition in the gut.

Authors:  Yanna Cao; Xuxia Gao; Weili Zhang; Guohua Zhang; Anthony K Nguyen; Xianghua Liu; Fernando Jimenez; Charles S Cox; Courtney M Townsend; Tien C Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-31       Impact factor: 4.052

6.  ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.

Authors:  Annette M May; Anna-Verena Frey; Lioudmila Bogatyreva; Marco Benkisser-Petersen; Dieter Hauschke; Michael Lübbert; Ralph Wäsch; Martin Werner; Jens Hasskarl; Silke Lassmann
Journal:  Histochem Cell Biol       Date:  2013-11-30       Impact factor: 4.304

7.  TGF-beta repression of Id2 induces apoptosis in gut epithelial cells.

Authors:  Y Cao; X Liu; W Zhang; X Deng; H Zhang; Y Liu; L Chen; E A Thompson; C M Townsend; T C Ko
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

8.  ID1 promotes breast cancer metastasis by S100A9 regulation.

Authors:  Kiranmai Gumireddy; Anping Li; Andrew V Kossenkov; Kathy Q Cai; Qin Liu; Jinchun Yan; Hua Xu; Louise Showe; Lin Zhang; Qihong Huang
Journal:  Mol Cancer Res       Date:  2014-06-19       Impact factor: 5.852

9.  Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers.

Authors:  Min Khine Maw; Jiro Fujimoto; Teruhiko Tamaya
Journal:  BMC Cancer       Date:  2009-12-10       Impact factor: 4.430

10.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.